Ensysce Biosciences (ENSC) Other Non Operating Income (2018 - 2025)
Ensysce Biosciences (ENSC) reported Other Non Operating Income of $17,338 for Q3 2025, up 18.1% from $14,683 a year earlier but down 17.5% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Other Non Operating Income (2018 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Ensysce Biosciences' Other Non Operating Income came in at $83,918; for FY2024, it came in at $17,277, up 12.0% from FY2023.
- Other Non Operating Income has a five-year compound annual growth rate of -63.9% (FY2019 to FY2024).
- By year, Other Non Operating Income came in at $15,420 in FY2023 (-82.1%), $86,223 in FY2022 (-87.2%), $673,314 in FY2021 (-88.6%) and $5.92 million in FY2020 (+110.3%).
- Five-year quarterly Other Non Operating Income spans a low of -$347,566 in Q2 2021 and a high of $4.84 million in Q4 2020.
- Year over year, Other Non Operating Income gained in three of the last four quarters, with growth averaging 70.3%.
- The high point for year-over-year Other Non Operating Income in five years was Q2 2023 (growth of 287.0%); the low point was Q1 2022 (a decline of 99.5%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $21,011 (Q2 2025), $15,879 (Q1 2025) and $29,690 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Ensysce Biosciences | 1.02 Mn | -10.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 17,338.00 |
| Jun 30, 2025 | 21,011.00 |
| Mar 31, 2025 | 15,879.00 |
| Dec 31, 2024 | 29,690.00 |
| Sep 30, 2024 | 14,683.00 |
| Jun 30, 2024 | 7,394.00 |
| Mar 31, 2024 | -34,489.00 |
| Dec 31, 2023 | -7,962.00 |
| Sep 30, 2023 | 6,934.00 |
| Jun 30, 2023 | 11,030.00 |
| Mar 31, 2023 | 5,419.00 |
| Dec 31, 2022 | 66,729.00 |
| Sep 30, 2022 | 8,679.00 |
| Jun 30, 2022 | 2,850.00 |
| Mar 31, 2022 | 7,966.00 |
| Sep 30, 2021 | 61,758.00 |
| Jun 30, 2021 | -347,566.00 |
| Mar 31, 2021 | 1.48 Mn |
| Dec 31, 2020 | 4.84 Mn |
| Sep 30, 2020 | 2.17 Mn |
API Access
Ensysce Biosciences Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();